12/10
07:18 am
neup
Neuphoria Therapeutics (NASDAQ:NEUP) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Medium
Report
Neuphoria Therapeutics (NASDAQ:NEUP) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
12/8
08:00 am
neup
Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria’s Director Nominees
Medium
Report
Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria’s Director Nominees
12/5
08:09 am
neup
Neuphoria Therapeutics (NASDAQ:NEUP) had its price target lowered by analysts at HC Wainwright from $21.00 to $7.00. They now have a "buy" rating on the stock.
Low
Report
Neuphoria Therapeutics (NASDAQ:NEUP) had its price target lowered by analysts at HC Wainwright from $21.00 to $7.00. They now have a "buy" rating on the stock.
12/4
08:00 am
neup
Neuphoria Responds to Lynx1’s Revised Indication of Interest at a Reduced Price and Premium
Low
Report
Neuphoria Responds to Lynx1’s Revised Indication of Interest at a Reduced Price and Premium
12/2
08:06 pm
neup
Lynx1 Sends Open Letter to Fellow Neuphoria Shareholders [Yahoo! Finance]
Medium
Report
Lynx1 Sends Open Letter to Fellow Neuphoria Shareholders [Yahoo! Finance]
12/1
08:10 am
neup
Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions [Yahoo! Finance]
Low
Report
Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions [Yahoo! Finance]
12/1
08:00 am
neup
Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions
Low
Report
Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions
11/24
08:00 am
neup
Neuphoria Therapeutics Inc. Sends Letter to Stockholders
Medium
Report
Neuphoria Therapeutics Inc. Sends Letter to Stockholders
11/23
02:11 am
neup
Neuphoria Therapeutics (NASDAQ:NEUP) was downgraded by analysts at
Wall
Low
Report
Neuphoria Therapeutics (NASDAQ:NEUP) was downgraded by analysts at
Wall
11/23
02:11 am
neup
Neuphoria Therapeutics (NASDAQ:NEUP) was downgraded by analysts at
Wall
Low
Report
Neuphoria Therapeutics (NASDAQ:NEUP) was downgraded by analysts at
Wall
11/15
01:42 am
neup
Neuphoria Therapeutics (NASDAQ:NEUP) was upgraded by analysts at
Wall St
Medium
Report
Neuphoria Therapeutics (NASDAQ:NEUP) was upgraded by analysts at
Wall St
11/11
07:26 am
neup
Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value [Yahoo! Finance]
Medium
Report
Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value [Yahoo! Finance]
11/11
07:00 am
neup
Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value
Low
Report
Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value
11/1
01:05 am
neup
Neuphoria Therapeutics (NASDAQ:NEUP) was downgraded by analysts at
Wall
Low
Report
Neuphoria Therapeutics (NASDAQ:NEUP) was downgraded by analysts at
Wall
10/27
04:29 pm
neup
Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process
Low
Report
Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process
10/8
12:30 pm
neup
Neuphoria Therapeutics (NASDAQ:NEUP) was downgraded by analysts at
Weiss Ratings from a "hold (c-)" rating to a "sell (d-)" rating.
Low
Report
Neuphoria Therapeutics (NASDAQ:NEUP) was downgraded by analysts at
Weiss Ratings from a "hold (c-)" rating to a "sell (d-)" rating.
9/29
05:32 pm
neup
Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates [Yahoo! Finance]
Low
Report
Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates [Yahoo! Finance]
9/29
04:54 pm
neup
Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates
Low
Report
Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates